| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 02/18/2010 | WO2010018223A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 02/18/2010 | WO2010018222A1 Nanocrystal nano-emulsion |
| 02/18/2010 | CA2733963A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 02/18/2010 | CA2733959A1 Nanocrystal nano-emulsion |
| 02/17/2010 | EP1799748B1 Biodegradable cationic polymers |
| 02/16/2010 | US7662807 Sulphonated meso-tetraphenyl chlorins |
| 02/16/2010 | US7662360 boron neutron capture therapy |
| 02/11/2010 | WO2010016581A1 Ultrasonic cancer therapy accelerator |
| 02/11/2010 | US20100034828 Method of Increasing Radiation Sensitivity by Inhibition of Beta One Integrin |
| 02/10/2010 | EP2150278A1 Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy |
| 02/10/2010 | CN100588436C Ultrasonic sonophoresis skin care device |
| 02/09/2010 | US7659301 Controlling photoactivation; reducing oxygen concentration of tissue at site; prevention metabolism; cooling |
| 02/09/2010 | CA2353612C Boron neutron capture therapy using pre-targeting methods |
| 02/06/2010 | CA2660507A1 Targeted nanoparticles for cancer diagnosis and treatment |
| 02/04/2010 | WO2010014728A1 Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth |
| 02/04/2010 | WO2010014676A1 Composition and method for treatment of mrsa |
| 02/04/2010 | WO2010013137A1 Active particles for bio-analytical applications and methods for preparation thereof |
| 02/04/2010 | WO2010013136A2 Active particles for bio-analytical applications and methods for their preparation |
| 02/04/2010 | CA2733001A1 Of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth |
| 02/04/2010 | CA2732307A1 Composition and method for treatment of mrsa |
| 02/03/2010 | EP2149372A1 Use of opioids or opioid mimetics for the treatment of resistant cancer patients |
| 02/03/2010 | CN101638411A Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 02/02/2010 | US7655753 Conjugate |
| 02/02/2010 | US7655694 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 01/28/2010 | WO2010011327A2 Radiative heating for drug delivery and other applications |
| 01/28/2010 | WO2010011326A2 Heating of polymers-and other materials using radiation for drug delivery and other applications |
| 01/26/2010 | CA2529374C Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 01/21/2010 | WO2010006722A1 Contrast agent-reinforced radiotherapy having high-output tubes |
| 01/21/2010 | US20100016613 Process for the preparation of a boron-substituted porphyrin |
| 01/19/2010 | US7649013 Administering to a subject in need thereof, prior to an exposure to radiation, a therapeutically effective amount of a modulator of cell cycle checkpoint activation, or a pharmaceutically acceptable salt, prodrug, metabolite, analog or derivative thereof, in particular, beta-lapachone |
| 01/19/2010 | US7648695 A halogenated xanthene derivative, preferably Rose Bengal; can be delivered at high concentrations to certain tissues |
| 01/14/2010 | WO2010003668A2 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 01/13/2010 | EP2143442A1 Treatment of solid tumors with tissue inhibitors of metalloproteinases(TIMPs) |
| 01/13/2010 | EP2142199A2 A process to activate extracts derived from living organisms using long wave uv irradiation and compositions comprising said activated extract |
| 01/13/2010 | EP2142180A2 Therapeutic plaster for trigger and acupuncture points and for meridian therapy |
| 01/13/2010 | EP2141995A1 Compositions and methods for protecting cells from toxic exposures |
| 01/13/2010 | EP1427462B1 Method for inducing selectively suppressed immune response |
| 01/13/2010 | EP1255725B1 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 01/13/2010 | EP0723548B1 Phosphorescent compounds for imaging tissue oxygen |
| 01/13/2010 | CN101626786A Integrated photoactive peptides and uses thereof |
| 01/12/2010 | CA2211517C Uses of compositions comprising gaseous precursors as potentiators for ultrasonic hyperthermia |
| 01/12/2010 | CA2197435C Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias |
| 01/07/2010 | WO2010001102A2 Method |
| 01/07/2010 | CA2729369A1 Method |
| 01/06/2010 | EP2056820B1 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof |
| 01/05/2010 | US7641643 Methods and compositions to treat myocardial conditions |
| 12/30/2009 | WO2009072079A3 Polymeric drug carrier for image-guided delivery |
| 12/30/2009 | EP2138191A1 Enhanced transport using membrane disruptive agents |
| 12/30/2009 | EP2138180A1 A composition for treating cancer containing a porous silicon nanobomb as an active ingredient |
| 12/30/2009 | EP1409482B1 Dye-sulfenates for dual phototherapy |
| 12/29/2009 | US7638139 Heat source kills cells without protein denaturization; liposomes; age related macular degeneration |
| 12/29/2009 | US7638122 Stat3 antagonists and their use as vaccines against cancer |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/23/2009 | WO2009060186A8 Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias |
| 12/23/2009 | EP2135942A1 Method for suppressing immune system response to transplanted tissue or cells |
| 12/23/2009 | EP2134368A1 Homeopathic medicament useful for immunomodulation |
| 12/23/2009 | EP2134367A2 Integrated photoactive peptides and uses thereof |
| 12/23/2009 | CN101606933A Dihydro porphin photosensitizer, preparation method and application thereof |
| 12/23/2009 | CA2728402A1 Apparatus and methods for controlling cellular development |
| 12/22/2009 | US7635722 Chemical induced intracellular hyperthermia |
| 12/17/2009 | WO2009152372A1 Control of blood vessel physiology to treat skin disorders |
| 12/17/2009 | US20090311215 Method for treating cervical cancer |
| 12/17/2009 | CA2727710A1 Control of blood vessel physiology to treat skin disorders |
| 12/16/2009 | EP2131862A1 A method for non-therapeutic or therapeutic photodynamic skin treatment |
| 12/15/2009 | US7632413 Treat blood with ultrasound, ultraviolet radiation, infrared, microwaves; without cavitation, heating, ozone; luekemia, viral blood infections, cancers |
| 12/10/2009 | WO2009147214A2 Inorganic nanoparticles, preparation and uses thereof |
| 12/10/2009 | WO2009123575A8 A photosensitising composition and its uses |
| 12/10/2009 | US20090306455 Method of Providing Magnetised Particles at a Location |
| 12/10/2009 | US20090305418 Cell therapy method for the treatment of tumors |
| 12/10/2009 | US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 12/10/2009 | CA2727576A1 Inorganic nanoparticles, preparation and uses thereof |
| 12/09/2009 | EP2130837A1 Novel nuclear translocation peptide |
| 12/09/2009 | EP2130834A1 Novel sulfonated sugar derivative, and use thereof for medicinal agent |
| 12/09/2009 | EP2130553A1 Inorganic nanoparticles of high density to destroy cells in-vivo |
| 12/03/2009 | WO2009144775A1 Anti-tumor agent |
| 12/03/2009 | WO2009143610A1 Modulating interstitial pressure and oncolytic viral delivery and distribution |
| 12/03/2009 | US20090299268 Topical Aminolevulinic Acid-Photodynamic Therapy for the Treatment of Acne Vulgaris |
| 12/03/2009 | US20090297567 Method For Ultrasound Triggered Drug Delivery Using Hollow Microbubbles With Controlled Fragility |
| 12/03/2009 | CA2723580A1 Modulating interstitial pressure and oncolytic viral delivery and distribution |
| 12/02/2009 | EP2128095A1 Spherical ferrite nanoparticle and method for production thereof |
| 12/02/2009 | EP2124936A2 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities |
| 12/02/2009 | EP1534347B1 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 12/02/2009 | CN101591341A Alkyl porphyrin compound, preparation and application thereof in field of medicaments and pesticides |
| 12/02/2009 | CN101591340A 5,10,15,20-tetra-(5-drewamine amyl)-chlorin, preparation and application thereof in field of medicaments and pesticides |
| 12/02/2009 | CN100563718C Gas-filled microvesicle assembly for contrast imaging |
| 12/01/2009 | US7625562 Generation of cartilage using magnetizable particles |
| 12/01/2009 | US7625557 Transimmunization methods incorporating skin immunologic challenges are described for selectively suppressing immune response of recipients of transplanted tissue or cells or monitoring induced anti-cancer immunity |
| 11/26/2009 | WO2009026430A3 Liposome formulations of boronic acid compounds |
| 11/25/2009 | EP2120921A2 Use of aminolevulinic acid and derivatives thereof |
| 11/25/2009 | EP2120722A1 Method of controlling a release of a material carried by ultrasound sensitive particles |
| 11/24/2009 | US7622439 Method to enhance hemodynamic stability using oxygen carrying compositions |
| 11/24/2009 | CA2279427C Use of low dose photodynamic therapy for reducing the effects of inflammation |
| 11/19/2009 | WO2009137889A1 Polymer microgel beads |
| 11/19/2009 | WO2009137888A1 Polymer microgel beads and preparative method thereof |
| 11/19/2009 | WO2008139457A3 Ph-dependent drug targeting |
| 11/19/2009 | US20090286743 Methods and Compositions for Treating Conditions of the Eye |
| 11/19/2009 | US20090285778 Use of interleukin-19 to treat cervical cancer |
| 11/19/2009 | CA2724178A1 Polymer microgel beads |
| 11/19/2009 | CA2724177A1 Polymer microgel beads and preparative method thereof |
| 11/18/2009 | EP2117600A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |